Orexigen Therapeutics Inc (NASDAQ:OREX)

During the Trading Day
7.83 +0.08 / +1.03%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.89 +0.06 / +0.77%
 
Volume: 1.8K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-28.1M-90.1M-77.7M-37.5M
 
 
 
 
 
Depreciation443.0K313.0K94.0K139.0K
 
 
 
 
 
Total Other Cash Flow7.7M8.1M8.6M20.0M
 
 
 
 
 
Funds From Operations-19.9M-81.7M-69.0M-17.4M
 
 
 
 
 
Funds From/For Other Operating Expenses9.3M-13.3M1.8M-44.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-29.2M-68.3M-70.8M26.8M
 
 
 
 
 
 
InvestingIncrease In Investments-73.0M-78.9M-85.6M-130.4M
 
 
 
 
 
Decrease In Investments93.8M65.6M65.0M107.2M
 
 
 
 
 
Capital Expenditures0.000.00-640.0K-246.0K
 
 
 
Other Investing - Sources339.0K0.000.000.00
 
 
Net Cash Flow Investing21.1M-13.3M-21.3M-23.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.00110.5M0.00
 
 
Long Term Debt Reduction-2.4M0.000.000.00
 
 
Net Proceeds Stock Sale87.4M58.3M1.3M2.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing85.0M58.3M111.9M2.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash76.8M-23.4M19.8M6.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account